Literature DB >> 9820402

Steatorrhea and weight loss in a 72-year-old man: primary biliary cirrhosis? Celiac disease? Bacterial overgrowth? What else?

J K DiBaise1, F F Paustian.   

Abstract

Unintentional weight loss is an ominous sign, particularly when it occurs in the elderly; concern for malignancy is especially worrisome. In this report, we describe a 72-yr-old man who presented with weight loss and was found to have massive steatorrhea. An extensive evaluation revealed evidence of primary biliary cirrhosis (PBC), celiac disease, and small intestinal bacterial overgrowth. No malignancy was identified. The weight loss was attributed to severe steatorrhea due, in part, to intraluminal bile salt deficiency, small bowel mucosal disease, and bacterial overgrowth. Several points are discussed regarding gastrointestinal function in elderly patients with chronic liver disease secondary to PBC. The rare association between PBC and celiac disease in adults is also discussed. Finally, we suggest that bacterial overgrowth plays a significant role in the development of steatorrhea in some persons with PBC and that an assessment for bacterial overgrowth should be performed on persons with steatorrhea and PBC.

Entities:  

Mesh:

Year:  1998        PMID: 9820402     DOI: 10.1111/j.1572-0241.1998.00620.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  3 in total

Review 1.  Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 2.  Aging and intestinal motility: a review of factors that affect intestinal motility in the aged.

Authors:  Denis O'Mahony; Paula O'Leary; Eamonn M M Quigley
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 3.  To screen or not to screen? Celiac antibodies in liver diseases.

Authors:  Janaína Luz Narciso-Schiavon; Leonardo Lucca Schiavon
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.